(R)-1-Benzyl 3-methyl piperazine-1,3-dicarboxylate hydrochloride

Catalog No. :
ACZCXI486
CAS No. :
1217442-12-0
Molecular Formula :
C14H19ClN2O4
Molecular Weight :
314.77

IUPAC Name:1-benzyl 3-methyl (R)-piperazine-1,3-dicarboxylate hydrochloride

(R)-1-Benzyl 3-methyl piperazine-1,3-dicarboxylate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$183.00Login to see priceInquiryInquiry
250mg97%$330.00Login to see priceInquiryInquiry
1g97%$823.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-1-Benzyl 3-methyl piperazine-1,3-dicarboxylate hydrochloride
IUPAC Name1-benzyl 3-methyl (R)-piperazine-1,3-dicarboxylate hydrochloride
MDL No.MFCD11053717
Molecular FormulaC14H19ClN2O4
Molecular Weight314.77
SMILESO=C(N1C[C@H](C(OC)=O)NCC1)OCC2=CC=CC=C2.[H]Cl
InChI KeyKBTDRWBNFLCGPG-UTONKHPSSA-N
Synonym(R)-1-Benzyl 3-Methyl piperazine-1,3-dicarboxylate hydrochloride;(R)-4-CBZ-PIPERAZINE-2-CARBOXYLIC ACID METHYL ESTER HCL;1-Benzyl3-methyl(R)-piperazine-1,3-dicarboxylatehydrochloride
CAS No.1217442-12-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACZCXI486 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKZUJ860 route compound structure diagram
    ACKZUJ860278790-00-4 In Stock
  2. Then
  3. ACZCXI486 route product structure diagram
    ACZCXI4861217442-12-0
Inquiry

2. ACZCXI486 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZCXI486 route product structure diagram
    ACZCXI4861217442-12-0
Inquiry

Comments (0)